Ionis Pharmaceuticals (IONS) Short Interest Ratio & Short Volume $31.91 +1.20 (+3.89%) As of 11:15 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Ionis Pharmaceuticals Short Interest DataIonis Pharmaceuticals (IONS) has a short interest of 14.55 million shares, representing 9.41% of the float (the number of shares available for trading by the public). This marks a 9.07% increase in short interest from the previous month. The short interest ratio (days to cover) is 8.3, indicating that it would take 8.3 days of the average trading volume of 1.70 million shares to cover all short positions.Current Short Interest14,550,000 sharesPrevious Short Interest13,340,000 sharesChange Vs. Previous Month+9.07%Dollar Volume Sold Short$412.93 millionShort Interest Ratio8.3 Days to CoverLast Record DateApril 15, 2025Outstanding Shares158,965,000 sharesFloat Size154,570,000 sharesShort Percent of Float9.41%Today's Trading Volume626,409 sharesAverage Trading Volume1,696,455 sharesToday's Volume Vs. Average37% Short Selling Ionis Pharmaceuticals? Sign up to receive the latest short interest report for Ionis Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartIONS Short Interest Over TimeIONS Days to Cover Over TimeIONS Percentage of Float Shorted Over Time Ionis Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202514,550,000 shares $412.93 million +9.1%9.4%8.3 $28.38 3/31/202513,340,000 shares $402.47 million +4.1%8.6%7.7 $30.17 3/15/202512,810,000 shares $422.22 million -0.3%8.3%7.8 $32.96 2/28/202512,850,000 shares $426.49 million +1.4%8.3%7.8 $33.19 2/15/202512,670,000 shares $393.28 million +4.5%8.2%7.7 $31.04 1/31/202512,120,000 shares $386.63 million +18.4%7.9%7.9 $31.90 1/15/202510,240,000 shares $340.07 million -6.1%7.0%7.1 $33.21 12/31/202410,900,000 shares $381.06 million +3.5%7.5%7.8 $34.96 12/15/202410,530,000 shares $385.50 million +0.8%7.2%7.1 $36.61 11/30/202410,450,000 shares $373.38 million -5.4%7.2%6.1 $35.73 Get the Latest News and Ratings for IONS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ionis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/15/202411,050,000 shares $379.46 million +2.9%7.6%6.5 $34.34 10/31/202410,740,000 shares $412.31 million +8.8%7.4%7 $38.39 10/15/20249,870,000 shares $373.48 million -6.3%6.8%6.3 $37.84 9/30/202410,530,000 shares $421.83 million -0.8%7.2%6.6 $40.06 9/15/202410,610,000 shares $447.64 million +4.4%7.3%6.4 $42.19 8/31/202410,160,000 shares $484.43 million +2.6%7.6%6.8 $47.68 8/15/20249,900,000 shares $461.98 million +4.7%7.4%8 $46.67 7/31/20249,460,000 shares $467.89 million +1.0%7.0%7 $49.46 7/15/20249,370,000 shares $445.73 million -1.6%7.0%7.2 $47.57 6/30/20249,520,000 shares $453.72 million +10.1%7.1%7.8 $47.66 6/15/20248,650,000 shares $351.62 million +0.6%6.5%7.5 $40.65 5/31/20248,600,000 shares $323.10 million -0.4%6.4%8.3 $37.57 5/15/20248,630,000 shares $338.38 million -1.4%6.4%7.9 $39.21 4/30/20248,750,000 shares $361.03 million -8.2%6.5%8.1 $41.26 4/15/20249,530,000 shares $395.97 million +0.1%7.1%8.9 $41.55 3/31/20249,520,000 shares $412.69 million -1.6%7.1%8.2 $43.35 3/15/20249,670,000 shares $411.46 million +6.2%7.2%8.1 $42.55 2/29/20249,110,000 shares $411.86 million +0.6%6.8%7.4 $45.21 2/15/20249,060,000 shares $410.24 million +7.2%6.8%7.4 $45.28 1/31/20248,450,000 shares $434.25 million -1.1%6.0%7.5 $51.39 1/15/20248,540,000 shares $457.23 million +3.6%6.1%7.4 $53.54 12/31/20238,240,000 shares $416.86 million -3.7%5.9%7.5 $50.59 12/15/20238,560,000 shares $425.43 million -11.8%6.1%7.3 $49.70 11/30/20239,700,000 shares $479.86 million -0.4%6.9%8.7 $49.47 11/15/20239,740,000 shares $484.76 million +0.4%7.0%9.4 $49.77 10/31/20239,700,000 shares $429.42 million +6.2%6.9%9.6 $44.27 10/15/20239,130,000 shares $438.06 million -1.8%6.5%9 $47.98 9/30/20239,300,000 shares $421.85 million -0.9%6.6%9.2 $45.36 9/15/20239,380,000 shares $402.50 million +1.0%6.7%10.1 $42.91 8/31/20239,290,000 shares $374.11 million -3.7%6.6%9.7 $40.27The Man I Turn to In Times Like This (Ad)A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.” Tilson just released a new prediction that runs counter to what mainstream finance is telling you.Market chaos? Hear Tilson’s take now 8/15/20239,650,000 shares $386 million +4.8%6.9%7.9 $40.00 7/31/20239,210,000 shares $381.57 million +4.0%6.6%7.3 $41.43 7/15/20238,860,000 shares $376.37 million +2.8%6.4%7 $42.48 6/30/20238,620,000 shares $353.68 million -0.8%6.2%7.2 $41.03 6/15/20238,690,000 shares $362.29 million +33.3%6.2%7.2 $41.69 5/31/20236,520,000 shares $266.67 million -8.3%4.7%5.5 $40.90 5/15/20237,110,000 shares $257.67 million No Change5.1%7.3 $36.24 10/31/20226,860,000 shares $303.21 million -2.0%4.9%6.9 $44.20 10/15/20227,000,000 shares $324.52 million -3.5%5.0%6.9 $46.36 9/30/20227,250,000 shares $320.67 million +6.6%5.2%7.4 $44.23 9/15/20226,800,000 shares $322.93 million +9.2%4.9%7.1 $47.49 8/31/20226,230,000 shares $264.90 million -7.7%4.5%6.8 $42.52 8/15/20226,750,000 shares $299.77 million +10.7%4.8%7.2 $44.41 7/31/20226,100,000 shares $229.12 million +0.5%4.4%6 $37.56 7/15/20226,070,000 shares $238.61 million +5.9%4.3%6.1 $39.31 6/30/20225,730,000 shares $212.12 million +1.4%4.1%5.3 $37.02 6/15/20225,650,000 shares $195.89 million -5.7%4.5%5.1 $34.67 5/31/20225,990,000 shares $218.75 million -16.1%4.3%5.5 $36.52 5/15/20227,140,000 shares $257.61 million +9.2%5.1%6.6 $36.08 4/30/20226,540,000 shares $240.41 million -12.2%4.7%6.1 $36.76 4/15/20227,450,000 shares $305.23 million +3.9%5.3%6.5 $40.97 3/31/20227,170,000 shares $265.58 million -1.7%N/A0 $37.04 3/15/20227,290,000 shares $238.38 million -4.1%5.2%6.6 $32.70 2/28/20227,600,000 shares $253.69 million -18.7%5.4%6.2 $33.38 2/15/20229,350,000 shares $314.72 million -1.8%6.7%7.2 $33.66 1/31/20229,520,000 shares $302.74 million +31.9%6.8%7.7 $31.80 1/15/20227,220,000 shares $238.84 million -1.5%N/A0 $33.08 12/31/20217,330,000 shares $223.05 million -0.8%5.3%6.4 $30.43 12/15/20217,390,000 shares $229.90 million +8.2%5.3%6.6 $31.11 11/30/20216,830,000 shares $181.00 million +10.3%4.9%6.4 $26.50 11/15/20216,190,000 shares $202.97 million -10.4%4.4%6.4 $32.79 10/29/20216,910,000 shares $220.22 million +1.9%5.0%7.5 $31.87 10/15/20216,780,000 shares $237.98 million +2.1%4.9%7.4 $35.10 9/30/20216,640,000 shares $222.71 million -7.4%4.8%7.7 $33.54 9/15/20217,170,000 shares $265.00 million -6.8%5.1%7.3 $36.96 8/31/20217,690,000 shares $305.75 million -8.5%5.5%7.7 $39.76 8/13/20218,400,000 shares $333.31 million -8.6%6.0%6.4 $39.68 7/30/20219,190,000 shares $341.32 million +7.2%6.6%6.1 $37.14 7/15/20218,570,000 shares $305.69 million -4.8%6.4%5.1 $35.67 6/30/20219,000,000 shares $359.01 million +0.3%6.7%5.3 $39.89 6/15/20218,970,000 shares $329.02 million -17.3%6.7%4.9 $36.68 5/28/202110,850,000 shares $404.16 million +1.0%8.1%5.7 $37.25 5/14/202110,740,000 shares $401.35 million +4.2%8.0%6.6 $37.37 4/30/202110,310,000 shares $446.63 million +6.7%7.7%7.1 $43.32 4/15/20219,660,000 shares $404.08 million +10.2%N/A7.5 $41.83 3/31/20218,770,000 shares $392.11 million +2.2%6.5%7.1 $44.71 3/15/20218,580,000 shares $454.65 million +0.9%6.4%7.3 $52.99 2/26/20218,500,000 shares $453.99 million +7.1%6.3%7.9 $53.41 2/12/20217,940,000 shares $460.12 million +5.2%6.0%7.4 $57.95 1/29/20217,550,000 shares $458.21 million +2.6%5.7%6.9 $60.69The Man I Turn to In Times Like This (Ad)A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.” Tilson just released a new prediction that runs counter to what mainstream finance is telling you.Market chaos? Hear Tilson’s take now 1/15/20217,360,000 shares $451.54 million -5.4%5.5%6.8 $61.35 12/31/20207,780,000 shares $445.02 million +7.8%5.9%6.8 $57.20 12/15/20207,220,000 shares $345.33 million +2.1%5.4%6.1 $47.83 11/30/20207,070,000 shares $361.49 million +4.1%5.3%6.7 $51.13 11/15/20206,790,000 shares $350.16 million -5.7%5.1%6.9 $51.57 10/30/20207,200,000 shares $337.32 million -11.8%5.4%7.6 $46.85 10/15/20208,160,000 shares $389.31 million +0.1%6.2%8.9 $47.71 9/30/20208,150,000 shares $386.72 million +3.0%6.1%9.8 $47.45 9/15/20207,910,000 shares $418.68 million +4.1%6.0%10.2 $52.93 8/31/20207,600,000 shares $414.20 million -0.7%5.7%10.4 $54.50 8/14/20207,650,000 shares $403.77 million -6.0%5.8%10 $52.78 7/31/20208,140,000 shares $468.54 million -4.6%6.1%10.3 $57.56 7/15/20208,530,000 shares $524.60 million -1.2%6.4%10.6 $61.50 6/30/20208,630,000 shares $508.82 million -5.8%6.5%10.4 $58.96 6/15/20209,160,000 shares $524.04 million +4.0%6.9%10.6 $57.21 5/29/20208,810,000 shares $495.21 million +4.6%6.7%9.4 $56.21 5/15/20208,420,000 shares $446.85 million +4.5%6.4%8.3 $53.07 IONS Short Interest - Frequently Asked Questions What is Ionis Pharmaceuticals' current short interest? Short interest is the volume of Ionis Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 14,550,000 shares of IONS short. 9.41% of Ionis Pharmaceuticals' shares are currently sold short. Learn More on Ionis Pharmaceuticals' current short interest. What is a good short interest ratio for Ionis Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IONS shares currently have a short interest ratio of 8.0. Learn More on Ionis Pharmaceuticals's short interest ratio. Which institutional investors are shorting Ionis Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Ionis Pharmaceuticals: CSS LLC IL, Wolverine Trading LLC, Torno Capital LLC, Royal Bank of Canada, Group One Trading LLC, Deutsche Bank AG, Citadel Advisors LLC, Jane Street Group LLC, Tudor Investment Corp ET AL, Two Sigma Securities LLC, Susquehanna International Group LLP, Concourse Financial Group Securities Inc., Walleye Trading LLC, Walleye Capital LLC, Barclays PLC, JPMorgan Chase & Co., Twin Tree Management LP, and Wolverine Asset Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Ionis Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.41% of Ionis Pharmaceuticals' floating shares are currently sold short. Is Ionis Pharmaceuticals' short interest increasing or decreasing? Ionis Pharmaceuticals saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 14,550,000 shares, an increase of 9.1% from the previous total of 13,340,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Ionis Pharmaceuticals' float size? Ionis Pharmaceuticals currently has issued a total of 158,965,000 shares. Some of Ionis Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Ionis Pharmaceuticals currently has a public float of 154,570,000 shares. How does Ionis Pharmaceuticals' short interest compare to its competitors? 9.41% of Ionis Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Ionis Pharmaceuticals: Biogen Inc. (2.37%), United Therapeutics Co. (3.77%), BioMarin Pharmaceutical Inc. (2.72%), Incyte Co. (3.90%), Neurocrine Biosciences, Inc. (4.58%), Exelixis, Inc. (6.85%), Exact Sciences Co. (5.88%), Repligen Co. (6.11%), Halozyme Therapeutics, Inc. (7.87%), Madrigal Pharmaceuticals, Inc. (23.94%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short Ionis Pharmaceuticals stock? Short selling IONS is an investing strategy that aims to generate trading profit from Ionis Pharmaceuticals as its price is falling. IONS shares are trading up $0.90 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Ionis Pharmaceuticals? A short squeeze for Ionis Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IONS, which in turn drives the price of the stock up even further. How often is Ionis Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IONS, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies BIIB Short Interest UTHR Short Interest BMRN Short Interest INCY Short Interest NBIX Short Interest EXEL Short Interest EXAS Short Interest RGEN Short Interest HALO Short Interest MDGL Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IONS) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ionis Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ionis Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IONS Stock Free IONS Stock Alerts